 G Protein-coupled receptors
|
|
Ion channels
|
|
Nuclear receptors
|
|
Protein kinases
|
|
Cytokines and receptors
|
|
Cell surface molecules and ligands
|
|
Transporters
|
|
 Enzymes
|
Oxidoreductases (EC1)
|
Transferases (EC2)
|
Hydrolases (EC3)
|
Lyases (EC4)
|
Isomerases (EC5)
|
Peptidylprolyl isomerase [EC:5.2.1.8]
|
Prostaglandin-E synthase [EC:5.3.99.3]
|
Thromboxane-A synthase [EC:5.3.99.5]
|
DNA topoisomerase [EC:5.99.1.-]
|
TOP1 [HSA:7150] [KO:K03163]
|
 D08618 Topotecan (BAN)
D02168 Topotecan hydrochloride (USAN) <JP/US>
D08086 Irinotecan (INN)
D01061 Irinotecan hydrochloride (USP) <JP/US>
D10642 Irinotecan sucrosofate (USAN)
D10367 Etirinotecan pegol (USAN/INN)
D10422 Etirinotecan pegol tetrahydrochloride (USAN)
D10427 Etirinotecan pegol tetratriflutate (USAN)
D03225 Belotecan hydrochloride (USAN)
D02756 Aclarubicin (USAN/INN)
D01911 Aclarubicin hydrochloride (JP18) <JP>
D11529 Trastuzumab deruxtecan (USAN/INN) <JP/US>
D10985 Sacituzumab govitecan (USAN/INN) <US>
D01432 Exatecan mesylate (USAN)
D03954 Edotecarin (USAN/INN)
D03977 Elsamitrucin (USAN/INN)
D04031 Rubitecan (USAN/INN)
D04822 Lurtotecan dihydrochloride (USAN)
D05385 Pegamotecan (USAN)
D09327 Cositecan (USAN)
D09679 Tenifatecan (USAN/INN)
D10464 Firtecan pegol (USAN/INN)
D12184 Patritumab deruxtecan (USAN/INN)
D12359 Datopotamab deruxtecan (USAN/INN)
D12753 Ifinatamab deruxtecan (INN)
|
TOP2 [HSA:7153 7155] [KO:K03164]
|
Ligases (EC6)
|
|
Nucleic acids
|
|
Not elsewhere classified
|
Target-based Classification of Drugs